Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.46
CI's Cash to Debt is ranked lower than
64% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.57 vs. CI: 0.46 )
Ranked among companies with meaningful Cash to Debt only.
CI' s Cash to Debt Range Over the Past 10 Years
Min: 0.28  Med: 0.79 Max: N/A
Current: 0.46
Equity to Asset 0.21
CI's Equity to Asset is ranked lower than
82% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.35 vs. CI: 0.21 )
Ranked among companies with meaningful Equity to Asset only.
CI' s Equity to Asset Range Over the Past 10 Years
Min: 0.04  Med: 0.10 Max: 0.21
Current: 0.21
0.04
0.21
Interest Coverage 13.13
CI's Interest Coverage is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.35 vs. CI: 13.13 )
Ranked among companies with meaningful Interest Coverage only.
CI' s Interest Coverage Range Over the Past 10 Years
Min: 8.06  Med: 9.68 Max: 12.47
Current: 13.13
8.06
12.47
F-Score: 7
WACC vs ROIC
4.80%
14.73%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.12
CI's Operating margin (%) is ranked higher than
86% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.11 vs. CI: 9.12 )
Ranked among companies with meaningful Operating margin (%) only.
CI' s Operating margin (%) Range Over the Past 10 Years
Min: 2  Med: 8.92 Max: 10.75
Current: 9.12
2
10.75
Net-margin (%) 5.73
CI's Net-margin (%) is ranked higher than
82% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CI: 5.73 )
Ranked among companies with meaningful Net-margin (%) only.
CI' s Net-margin (%) Range Over the Past 10 Years
Min: 1.53  Med: 6.04 Max: 9.74
Current: 5.73
1.53
9.74
ROE (%) 19.08
CI's ROE (%) is ranked higher than
85% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.89 vs. CI: 19.08 )
Ranked among companies with meaningful ROE (%) only.
CI' s ROE (%) Range Over the Past 10 Years
Min: 7  Med: 20.46 Max: 30.77
Current: 19.08
7
30.77
ROA (%) 3.76
CI's ROA (%) is ranked higher than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.73 vs. CI: 3.76 )
Ranked among companies with meaningful ROA (%) only.
CI' s ROA (%) Range Over the Past 10 Years
Min: 0.72  Med: 2.72 Max: 3.81
Current: 3.76
0.72
3.81
Revenue Growth (3Y)(%) 17.20
CI's Revenue Growth (3Y)(%) is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CI: 17.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.3  Med: 11.55 Max: 19
Current: 17.2
-2.3
19
EBITDA Growth (3Y)(%) 20.00
CI's EBITDA Growth (3Y)(%) is ranked higher than
79% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CI: 20.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -24.3  Med: 8.80 Max: 58.7
Current: 20
-24.3
58.7
EPS Growth (3Y)(%) 18.90
CI's EPS Growth (3Y)(%) is ranked higher than
77% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. CI: 18.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -32  Med: 6.15 Max: 65.3
Current: 18.9
-32
65.3
» CI's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CI Guru Trades in Q1 2015

Signature Select Canadian Fund 15,600 sh (New)
Louis Moore Bacon 8,196 sh (New)
Ronald Muhlenkamp 2,100 sh (New)
Steven Cohen 275,600 sh (+703.50%)
Larry Robbins 1,778,837 sh (+5.88%)
Joel Greenblatt 55,057 sh (+1.46%)
James Barrow 2,478,001 sh (+0.12%)
Mario Gabelli 10,050 sh (unchged)
Jeremy Grantham 2,200 sh (unchged)
Vanguard Health Care Fund 6,163,900 sh (unchged)
John Keeley 7,750 sh (unchged)
Mairs and Power 4,500 sh (unchged)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Dodge & Cox 10,315,208 sh (-0.35%)
Richard Pzena 4,718,281 sh (-8.54%)
Pioneer Investments 58,682 sh (-23.40%)
Ray Dalio 20,345 sh (-24.60%)
Paul Tudor Jones 6,800 sh (-25.98%)
David Dreman 1,786 sh (-56.42%)
» More
Q2 2015

CI Guru Trades in Q2 2015

Andreas Halvorsen 2,914,815 sh (New)
Louis Moore Bacon 54,500 sh (+564.96%)
Larry Robbins 2,821,469 sh (+58.61%)
Mairs and Power 4,695 sh (+4.33%)
David Dreman 1,847 sh (+3.42%)
James Barrow 2,507,689 sh (+1.20%)
Mario Gabelli 10,050 sh (unchged)
Ray Dalio Sold Out
Ronald Muhlenkamp Sold Out
Dodge & Cox 10,245,758 sh (-0.67%)
Vanguard Health Care Fund 5,811,731 sh (-5.71%)
Joel Greenblatt 47,694 sh (-13.37%)
John Keeley 6,530 sh (-15.74%)
Jeremy Grantham 1,800 sh (-18.18%)
Paul Tudor Jones 4,500 sh (-33.82%)
Pioneer Investments 37,382 sh (-36.30%)
Richard Pzena 2,705,286 sh (-42.66%)
Steven Cohen 1,500 sh (-99.46%)
» More
Q3 2015

CI Guru Trades in Q3 2015

Eric Mindich 1,132,490 sh (New)
John Burbank 44,206 sh (New)
Lee Ainslie 4,850 sh (New)
Jim Simons 212,800 sh (New)
Leon Cooperman 250,000 sh (New)
NWQ Managers 299,585 sh (New)
Jeremy Grantham 444,890 sh (+24616.11%)
Larry Robbins 4,595,790 sh (+62.89%)
Mario Gabelli 14,550 sh (+44.78%)
Joel Greenblatt 68,734 sh (+44.11%)
Dodge & Cox 12,879,034 sh (+25.70%)
Pioneer Investments 37,529 sh (+0.39%)
John Keeley 6,530 sh (unchged)
Mairs and Power 4,695 sh (unchged)
Andreas Halvorsen Sold Out
Steven Cohen Sold Out
James Barrow 2,501,884 sh (-0.23%)
Vanguard Health Care Fund 5,712,931 sh (-1.70%)
Signature Select Canadian Fund 14,600 sh (-6.41%)
Louis Moore Bacon 49,500 sh (-9.17%)
Paul Tudor Jones 3,915 sh (-13.00%)
Richard Pzena 1,882,912 sh (-30.40%)
David Dreman 847 sh (-54.14%)
» More
Q4 2015

CI Guru Trades in Q4 2015

Vanguard Health Care Fund 7,105,831 sh (+24.38%)
Mario Gabelli 15,800 sh (+8.59%)
Pioneer Investments 37,936 sh (+1.08%)
James Barrow 2,477,958 sh (-0.96%)
Richard Pzena 1,278,327 sh (-32.11%)
Jim Simons 25,300 sh (-88.11%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cigna Corp

Eric Mindich Buys Cigna, Sherwin-Williams Eton Park founder's recent investments
Guru Eric Mindich (Trades, Portfolio) is a Harvard graduate and hedge fund manager who founded the Eton Park Capital Management in 2004. The firm primarily focuses on long term value investments, and also invests for charitable organizations, endowments, pension funds, and family offices worldwide. In the third quarter of 2015, Mindich purchased 1,132,490 shares in Cigna Corp. (NYSE:CI) and 117,500 shares in Sherwin-Williams Co. (NYSE:SHW). Read more...
NWQ Managers Makes 10 New Buys in 3rd Quarter Taylor Morrison Home, Cigna, Haverty Furniture are leading acquisitions
NWQ Managers (Trades, Portfolio), a value-oriented money management firm, bought 10 new stakes in the third quarter, one more than it bought in the second quarter – although NWQ has acquired and sold one of the companies several times in recent years. Read more...
NWQ Managers Takes Stake in Homebuilding, Health Care Companies Prices of Taylor Morrison Home and Cigna have dropped recently
NWQ Managers (Trades, Portfolio) is led by a senior investment team with an average of 19 years of analytical experience. In May 2002, NWQ was purchased by Nuveen Investments, however, they have still kept the name NWQ, and remain as a sister company to Nuveen. Read more...
Columbia Value and Restructuring Fund's Q2 2015 Commentary Greater market volatility anticipated in second half of year
Fund performance Read more...
Weekly CFO Sells Highlight: Cigna Corp, Comcast Corp, and DexCom Inc.
According to GuruFocus Insider Data, the recent CFO sales were: Cigna Corp (NYSE:CI), Comcast Corp (NASDAQ:CMCSA), and DexCom Inc. (NASDAQ:DXCM). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 15.72
CI's P/E(ttm) is ranked higher than
75% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.10 vs. CI: 15.72 )
Ranked among companies with meaningful P/E(ttm) only.
CI' s P/E(ttm) Range Over the Past 10 Years
Min: 3.24  Med: 11.52 Max: 21.45
Current: 15.72
3.24
21.45
Forward P/E 12.64
CI's Forward P/E is ranked higher than
57% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.64 vs. CI: 12.64 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 15.62
CI's PE(NRI) is ranked higher than
83% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.68 vs. CI: 15.62 )
Ranked among companies with meaningful PE(NRI) only.
CI' s PE(NRI) Range Over the Past 10 Years
Min: 3.23  Med: 12.00 Max: 21.51
Current: 15.62
3.23
21.51
P/B 2.80
CI's P/B is ranked lower than
76% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.19 vs. CI: 2.80 )
Ranked among companies with meaningful P/B only.
CI' s P/B Range Over the Past 10 Years
Min: 0.52  Med: 2.20 Max: 3.96
Current: 2.8
0.52
3.96
P/S 0.88
CI's P/S is ranked lower than
95% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.46 vs. CI: 0.88 )
Ranked among companies with meaningful P/S only.
CI' s P/S Range Over the Past 10 Years
Min: 0.13  Med: 0.68 Max: 1.2
Current: 0.88
0.13
1.2
PFCF 18.88
CI's PFCF is ranked lower than
85% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.05 vs. CI: 18.88 )
Ranked among companies with meaningful PFCF only.
CI' s PFCF Range Over the Past 10 Years
Min: 1.8  Med: 15.32 Max: 149.61
Current: 18.88
1.8
149.61
POCF 14.89
CI's POCF is ranked lower than
83% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.48 vs. CI: 14.89 )
Ranked among companies with meaningful POCF only.
CI' s POCF Range Over the Past 10 Years
Min: 1.52  Med: 11.60 Max: 46.51
Current: 14.89
1.52
46.51
EV-to-EBIT 9.76
CI's EV-to-EBIT is ranked higher than
55% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.85 vs. CI: 9.76 )
Ranked among companies with meaningful EV-to-EBIT only.
CI' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.3  Med: 8.10 Max: 17.6
Current: 9.76
3.3
17.6
EV-to-EBITDA 8.38
CI's EV-to-EBITDA is ranked lower than
59% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.67 vs. CI: 8.38 )
Ranked among companies with meaningful EV-to-EBITDA only.
CI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.5  Med: 6.70 Max: 11
Current: 8.38
2.5
11
PEG 1.34
CI's PEG is ranked higher than
64% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CI: 1.34 )
Ranked among companies with meaningful PEG only.
CI' s PEG Range Over the Past 10 Years
Min: 0.23  Med: 0.78 Max: 15.47
Current: 1.34
0.23
15.47
Shiller P/E 25.25
CI's Shiller P/E is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.55 vs. CI: 25.25 )
Ranked among companies with meaningful Shiller P/E only.
CI' s Shiller P/E Range Over the Past 10 Years
Min: 3.12  Med: 15.29 Max: 33.88
Current: 25.25
3.12
33.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.03
CI's Dividend Yield is ranked lower than
100% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.03 vs. CI: 0.03 )
Ranked among companies with meaningful Dividend Yield only.
CI' s Dividend Yield Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.57
Current: 0.03
0.02
0.57
Forward Dividend Yield 0.03
CI's Forward Dividend Yield is ranked lower than
100% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.83 vs. CI: 0.03 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.03
CI's Yield on cost (5-Year) is ranked lower than
100% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.14 vs. CI: 0.03 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.57
Current: 0.03
0.02
0.57
3-Year Average Share Buyback Ratio 0.30
CI's 3-Year Average Share Buyback Ratio is ranked higher than
64% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.60 vs. CI: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.7  Med: 4.70 Max: 11.9
Current: 0.3
-1.7
11.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.75
CI's Price/Tangible Book is ranked lower than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.90 vs. CI: 5.75 )
Ranked among companies with meaningful Price/Tangible Book only.
CI' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.46  Med: 3.89 Max: 27.98
Current: 5.75
1.46
27.98
Price/Projected FCF 1.15
CI's Price/Projected FCF is ranked lower than
52% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.10 vs. CI: 1.15 )
Ranked among companies with meaningful Price/Projected FCF only.
CI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.28  Med: 1.00 Max: 4.89
Current: 1.15
0.28
4.89
Price/Median PS Value 1.31
CI's Price/Median PS Value is ranked lower than
86% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.87 vs. CI: 1.31 )
Ranked among companies with meaningful Price/Median PS Value only.
CI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.36  Med: 1.02 Max: 1.7
Current: 1.31
0.36
1.7
Price/Peter Lynch Fair Value 1.02
CI's Price/Peter Lynch Fair Value is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.28 vs. CI: 1.02 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CI' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.35  Med: 0.62 Max: 2.96
Current: 1.02
0.35
2.96
Price/Graham Number 2.00
CI's Price/Graham Number is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.29 vs. CI: 2.00 )
Ranked among companies with meaningful Price/Graham Number only.
CI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.89  Med: 1.59 Max: 3.72
Current: 2
0.89
3.72
Earnings Yield (Greenblatt) (%) 10.26
CI's Earnings Yield (Greenblatt) (%) is ranked higher than
68% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.90 vs. CI: 10.26 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5.7  Med: 12.30 Max: 29.9
Current: 10.26
5.7
29.9
Forward Rate of Return (Yacktman) (%) 18.85
CI's Forward Rate of Return (Yacktman) (%) is ranked higher than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.97 vs. CI: 18.85 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.9  Med: 16.60 Max: 51.6
Current: 18.85
-2.9
51.6

More Statistics

Revenue(Mil) $37276
EPS $ 8.17
Beta0.42
Short Percentage of Float0.93%
52-Week Range $113.25 - 170.68
Shares Outstanding(Mil)257.60

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 37,623 40,104 42,210 45,131
EPS($) 8.36 9.28 10.24 11.15
EPS without NRI($) 8.36 9.28 10.24 11.15

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:CGN.Germany,
Cigna Corp was incorporated in the State of Delaware in 1981. It is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the U.S., the majority of these products and services are offered through employers and other groups and, in selected international markets. It offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. The Company's segments are Global Health Care, Group Disability and Life, Global Supplemental Benefits, Run-off Reinsurance and Other Operations including Corporate-owned Life Insurance. The Global Health Care aggregates two operating segments namely Commercial that includes the international health care business and Government. The Company's Global Health Care segment offers insured and self-funded medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services that might be integrated to provide individuals with complete health care benefit programs. The Company's Group Disability and Life segment provides the insurance products and their related services such as group life insurance, long-term and short-term disability insurance, workers' compensation and disability case management, and accident and specialty insurance. The Global Supplemental Benefits segment is comprised of the international supplemental health, life and accident businesses as well as the Medicare supplement business. This segment offers supplemental health, life and accident insurance products in the U.S. and selected international markets. With local licenses and partnerships in approximately 20 countries and jurisdictions, it is able to offer products and services to local citizens and in other international markets. These products and services are provided by subsidiaries of the Company, including foreign operating entities. The products and services related to these operations were offered by subsidiaries of Cigna Corporation. Other Operations of the Company consists of: non-leveraged and leveraged corporate-owned life insurance; deferred gains recognized from the sale of the individual life insurance and annuity business and the sale of the retirement benefits business and run-off settlement annuity business. The Company's International's life, accident and supplemental health insurance products are sold mainly through direct marketing channels, such as outbound telemarketing, in-branch bancassurance and direct response television. In the HealthCare business, it competes with: insurance companies that provide group health and life insurance products, Blue Cross and Blue Shield organizations; stand-alone HMOs and PPOs; HMOs affiliated with insurance companies and hospitals and national managed pharmacy, beh
» More Articles for CI

Headlines

Articles On GuruFocus.com
Pzena Trades in Familiar Companies in 4th Quarter Feb 07 2016 
Eric Mindich Buys Cigna, Sherwin-Williams Dec 28 2015 
GAMCO Asset Fund's Quarterly Commentary Dec 24 2015 
Cooperman's Best Performing Stocks Include Amazon, Facebook Dec 17 2015 
NWQ Managers Makes 10 New Buys in 3rd Quarter Dec 16 2015 
NWQ Managers Takes Stake in Homebuilding, Health Care Companies Dec 12 2015 
5 Undervalued Companies With a Low Beta Nov 19 2015 
Columbia Value and Restructuring Fund Q2 2015 Commentary Oct 01 2015 
Weekly Insider Sells Highlight: Flowers Foods, Gilead Sciences, Cigna, HanesBrands Sep 22 2015 
Assurant's 67% Dividend Hike Makes a Fairly Valued Stock Sep 14 2015 

More From Other Websites
Cigna Assists People Affected by Police Shooting Outside Baltimore With 24x7 Telephone Help Line Feb 11 2016
Cigna Is Trading at a Discount pending the Anthem-Cigna Deal Feb 11 2016
Cigna’s Earnings Margin Falls due to Increased Medical Costs Feb 11 2016
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Cigna... Feb 10 2016
IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against... Feb 09 2016
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Cigna... Feb 09 2016
Strong Sales Drove Cigna’s Global Revenue Growth in 2015 Feb 09 2016
Cigna’s Diversification Strategy Boosts Its 4Q15 Earnings Feb 09 2016
UPDATE 1-Novartis sets heart-drug price with two insurers based on health outcome Feb 09 2016
CIGNA CORPORATION Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor... Feb 09 2016
[$$] Novartis Reaches Entresto Pay-for-Performance Deals With Cigna, Aetna Feb 09 2016
Cigna Foundation Makes Workplace Wellness a Global Priority; Announces World of Difference Grant to... Feb 09 2016
Cigna Foundation Makes Workplace Wellness a Global Priority; Announces World of Difference Grant to... Feb 09 2016
Cigna Foundation Makes Community Health Navigation a U.S. Priority; Announces World of Difference... Feb 09 2016
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Feb 09 2016
10:02 am CIGNA: Sequent Health Physician Partners collaborates with CIGNA (Feb 09 2016
Sequent Health Physician Partners Works with Cigna for Medical Group’s First Accountable Care... Feb 09 2016
Cigna Extends Collaborative Care to 75,000 Floridians Through New Arrangements with Five Medical... Feb 09 2016
Novartis sets heart-drug price with two insurers based on health outcome Feb 08 2016
Insurer Cigna and Novartis set heart-drug price based on health outcome Feb 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK